https://www.fool.com/earnings/call-transcripts/2019/10/31/momenta-pharmaceuticals-inc-mnta-q3-2019-earnings.aspx?source=iedfolrf0000001
Oct 31, 2019 - MNTA earnings call for the period ending September 30, 2019.
0
fool:-8596238666078372667
0
https://seekingalpha.com/article/4301058-momenta-pharmaceuticals-inc-mnta-ceo-craig-wheeler-q3-2019-results-earnings-call-transcript?source=feed_sector_healthcare
Oct 31, 2019 - Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Q3 2019 Earnings Conference Call October 31, 2019, 08:30 AM ET Company Participants Patty Eisenhaur - VP of IR and Corporate Communications Craig Wheeler -
0
sa:-4827418711513675347
0
http://www.zacks.com/stock/news/595198/momenta-pharmaceuticals-mnta-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-595198
Oct 31, 2019 - Momenta (MNTA) delivered earnings and revenue surprises of -14.29% and 39.06%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
zc:-220571346088786516
0
http://www.zacks.com/stock/news/582161/momenta-pharmaceuticals-mnta-expected-to-beat-earnings-estimates-should-you-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-582161
Oct 24, 2019 - Momenta (MNTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-1084575141154504202
0
https://seekingalpha.com/article/4260113-momenta-pharmaceuticals-inc-mnta-ceo-craig-wheeler-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare
May 05, 2019 - Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Q1 2019 Earnings Conference Call May 02, 2019, 08:30 ET Company Participants Patricia Eisenhaur - VP, IR & Communications Craig Wheeler - President, CEO
0
sa:-8941770806495558909
0
https://www.fool.com/earnings/call-transcripts/2019/05/02/momenta-pharmaceuticals-inc-mnta-q1-2019-earnings.aspx?source=iedfolrf0000001
May 02, 2019 - MNTA earnings call for the period ending March 31, 2019.
0
fool:7290428224185569415
0
http://www.zacks.com/stock/news/403482/momenta-pharmaceuticals-mnta-may-report-negative-earnings-know-the-trend-ahead-of-next-weeks-release?cid=CS-ZC-FT-403482
Apr 25, 2019 - Momenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-7104498015895742767
0
http://www.zacks.com/stock/news/365815/novartis-nvs-receives-fda-approval-for-ms-drug-mayzent?cid=CS-ZC-FT-365815
Mar 27, 2019 - Novartis (NVS) obtains FDA approval for Mayzent for the treatment of relapsing forms of MS.
zc:-7669265397575317010
0
http://www.zacks.com/stock/news/356858/momenta-mnta-q4-loss-narrower-than-expected-revenues-beat?cid=CS-ZC-FT-356858
Feb 25, 2019 - Momenta (MNTA) reported a narrower loss in Q4, while sales came ahead of expectations.
zc:1723976658267217271
0
https://www.fool.com/earnings/call-transcripts/2019/02/22/momenta-pharmaceuticals-mnta-q4-2018-earnings-conf.aspx?source=iedfolrf0000001
Feb 22, 2019 - MNTA earnings call for the period ending December 31, 2018.
0
fool:-1488369475888177217
0